Morgan Stanley ETF Trust - Eaton Vance Floating-Rate ETF (EVLN) Stock Price

48.82 ▲ +0.0195 (+0.04%)
Open: 48.76 Vol: 0 Day's range: 48.76 - 48.82 Sep 11, 10:16 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
EVLN Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY NEUTRAL
  5 mins 30 mins Hourly Daily Weekly
MA5 48.79▲ 48.79▲ 48.80▲ 48.82▲ 48.88▼
MA10 48.79▲ 48.80▲ 48.81▲ 48.82▲ 48.75▲
MA20 48.80▲ 48.80▲ 48.80▲ 48.85▼ 48.77▲
MA50 48.79▲ 48.85▼ 48.85▼ 48.74▲ 49.00▼
MA100 48.84▼ 48.81▲ 48.77▲ 48.78▲ 49.52▼
MA200 48.76▲ 48.74▲ 48.73▲ 48.91▼ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.000▲ 0.002▲ 0.003▲ -0.014▼ 0.046▲
RSI 55.558▲ 52.044▲ 51.363▲ 51.163▲ 49.841▼
STOCH 70.238     39.346     43.268     38.516     82.947▲
WILL %R 0.000▲ -29.412     -29.412     -66.667     -29.333    
CCI 197.436▲ 83.539     -38.095     -42.952     50.886    
Latest Filters Detected On EVLN
RSI $EVLN RSI(14) Crossed Above 50 Set Alert
CDL $EVLN Marubozu Candlestick Pattern Detected Set Alert
Morgan Stanley ETF Trust - Eaton Vance Floating-Rate ETF News
Enliven Therapeutics reports positive phase 1 CML data and FDA alignment for phase 3 trial (ELVN)
Thursday, June 11, 2026 07:36 AM
・Enliven Therapeutics (NASDAQ:ELVN) reported updated positive Phase 1 data for ELVN-001 in chronic myeloid leukemia (CML). ・The FDA aligned with the company on the Phase 3 dose and patient population ...
Why is Enliven Therapeutics (ELVN) One of the Best Performing Healthcare Stocks so Far in 2026?
Sunday, May 10, 2026 04:13 PM
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Why is Enliven Therapeutics (ELVN) One of the Best Performing Healthcare Stocks so Far in 2026?
Sunday, May 10, 2026 12:13 PM
Enliven Therapeutics, Inc. (NASDAQ:ELVN) is one of the best performing healthcare stocks so far in 2026. On April 30, Mizuho reaffirmed an Outperform rating on Enliven Therapeutics, Inc. (NASDAQ:ELVN) ...
EVLN historical stock data
date open high low close volume
11/09/26 48.76 48.82 48.76 48.82 1,976
10/09/26 48.79 48.84 48.77 48.8005 149,018
09/09/26 48.84 48.85 48.795 48.795 45,825
08/09/26 48.79 48.835 48.76 48.835 33,100
04/09/26 48.84 48.84 48.79 48.835 19,117
03/09/26 48.79 48.80 48.73 48.785 38,786
02/09/26 48.80 48.80 48.71 48.755 33,121
01/09/26 48.73 48.79 48.73 48.79 39,232
31/08/26 48.76 48.82 48.73 48.74 31,113
28/08/26 49.03 49.03 48.9801 49.01 14,265
Quote Details
52wk Low:48.08
52wk High:50.005
Vol:0
Avg Vol(3m):2M
1Y Chng:-2.23%
1M Chng:+0.97%
Add to Watch List
More Information
Sector N/A
Index N/A
Market Cap. 0.00